TY - JOUR
T1 - Speech-induced action myoclonus
AU - Simpson, Hugh D.
AU - Duffy, Joseph R.
AU - Stierwalt, Julie A.G.
AU - Ahlskog, J. Eric
AU - Hassan, Anhar
N1 - Funding Information:
Anhar Hassan has received research support from Intrabio and royalties from Mayo Scientific Publications.
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/5
Y1 - 2022/5
N2 - Background: Speech-induced action myoclonus may occur as a component of a generalized myoclonus syndrome. However, it may also present in isolation, or with a paucity of other findings, and be diagnostically challenging. Objectives: To report a retrospective case series of restricted speech-induced action myoclonus. Methods: We reviewed cases of speech-induced action myoclonus evaluated at Mayo Clinic Rochester from 1989 to 2020. We eliminated cases where a more generalized myoclonic disorder was also present. Clinical, imaging, and electrophysiologic data were extracted. Results: Four cases were identified in which speech-induced action myoclonus of craniofacial muscles was the predominant clinical presentation. All described cranial muscle twitching induced by speaking, and two cases also reported speech interruptions. Diagnosis was confirmed by expert speech pathologists in all cases. Diagnostic aids included modulation with different speech tasks and speaking rates, and surface electrophysiology which confirmed craniofacial myoclonus induced by speaking tasks (three cases). Previous misdiagnosis included functional, dystonic, neuromuscular junction pathology, or hemifacial spasm. Two cases had isolated speech-induced myoclonus, and the other two had coexistent upper limb tremor. Potential etiologic factors were identified in three cases – medication (2), epilepsy (1) – while in one patient no cause was identified. One patient partially improved with anti-myoclonic medication and speech therapy. Conclusions: Speech-induced action myoclonus may occur in isolation and is frequently misdiagnosed. Diagnostic aids include modulation with different speech tasks and speaking rates, and surface electrophysiology.
AB - Background: Speech-induced action myoclonus may occur as a component of a generalized myoclonus syndrome. However, it may also present in isolation, or with a paucity of other findings, and be diagnostically challenging. Objectives: To report a retrospective case series of restricted speech-induced action myoclonus. Methods: We reviewed cases of speech-induced action myoclonus evaluated at Mayo Clinic Rochester from 1989 to 2020. We eliminated cases where a more generalized myoclonic disorder was also present. Clinical, imaging, and electrophysiologic data were extracted. Results: Four cases were identified in which speech-induced action myoclonus of craniofacial muscles was the predominant clinical presentation. All described cranial muscle twitching induced by speaking, and two cases also reported speech interruptions. Diagnosis was confirmed by expert speech pathologists in all cases. Diagnostic aids included modulation with different speech tasks and speaking rates, and surface electrophysiology which confirmed craniofacial myoclonus induced by speaking tasks (three cases). Previous misdiagnosis included functional, dystonic, neuromuscular junction pathology, or hemifacial spasm. Two cases had isolated speech-induced myoclonus, and the other two had coexistent upper limb tremor. Potential etiologic factors were identified in three cases – medication (2), epilepsy (1) – while in one patient no cause was identified. One patient partially improved with anti-myoclonic medication and speech therapy. Conclusions: Speech-induced action myoclonus may occur in isolation and is frequently misdiagnosed. Diagnostic aids include modulation with different speech tasks and speaking rates, and surface electrophysiology.
KW - Action myoclonus
KW - Neurophysiology
KW - Speech
KW - Speech therapy
UR - http://www.scopus.com/inward/record.url?scp=85129136596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129136596&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2022.04.002
DO - 10.1016/j.parkreldis.2022.04.002
M3 - Article
C2 - 35468498
AN - SCOPUS:85129136596
SN - 1353-8020
VL - 98
SP - 41
EP - 46
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
ER -